Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2021-03-26
- Target Recruit Count
- 208
- Registration Number
- NCT04818099
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China
Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2021-03-19
- Last Posted Date
- 2023-04-14
- Target Recruit Count
- 57
- Registration Number
- NCT04807140
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2023-02-21
- Target Recruit Count
- 260
- Registration Number
- NCT04803539
- Locations
- 🇨🇳
Sunyat-sen Memorial Hospital, Guandong, Guangdong, China
Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma
- Conditions
- Oral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
- Interventions
- Procedure: Surgical resection
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2024-02-02
- Target Recruit Count
- 51
- Registration Number
- NCT04718415
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
🇨🇳Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guanzhou, Guangdong, China
Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2020-12-24
- Target Recruit Count
- 80
- Registration Number
- NCT04683445
- Locations
- 🇨🇳
Sun Yat Sen Memorial Hospital，Sun Yat sen University, Guangzhou, Guangdong, China
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2020-12-24
- Target Recruit Count
- 200
- Registration Number
- NCT04683770
- Locations
- 🇨🇳
Sun Yat Sen Memorial Hospital，Sun Yat sen University, Guangzhou, Guangdong, China
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2020-12-23
- Target Recruit Count
- 71
- Registration Number
- NCT04681911
- Locations
- 🇨🇳
Sun Yat Sen Memorial Hospital，Sun Yat sen University, Guangzhou, Guangdong, China
Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2020-11-30
- Last Posted Date
- 2020-11-30
- Target Recruit Count
- 516
- Registration Number
- NCT04646759
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Treatment of Bevacizumab Followed by Steroid in RN
- Conditions
- Nasopharyngeal CarcinomaAdverse Effect of Radiation TherapyBrain Injuries
- Interventions
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2020-09-17
- Target Recruit Count
- 86
- Registration Number
- NCT04553510
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
Artificial Intelligence Enables Precision Diagnosis of Cervical Cytology Grades and Cervical Cancer
- Conditions
- Cervical CancerDiagnosing Cervical Cytology Grades and CancerDiagnostic PlatformArtificial Intelligence
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2023-08-08
- Target Recruit Count
- 16164
- Registration Number
- NCT04551287
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
🇨🇳The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China